ZyVersa Therapeutics
- Biotech or pharma, therapeutic R&D
Biopharma with novel inflammasome ASC inhibitor (mAb) targeted at numerous CNS and other inflammatory diseases and P2a Cholesterol Efflux Mediator (2HPβCD) targeted at orphan renal diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}